Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

MEREO BIOPHARMA GROUP PLC

(MREO)
  Report
Delayed Nasdaq  -  04:00 2022-12-09 pm EST
0.7798 USD   -1.92%
12/07Pharama Stocks Nudge European Equities Modestly Higher in Wednesday Trading
MT
12/05After Seesaw Opening, European Equities Little Changed in Monday Trading
MT
12/02European Equities Move Lower to End Strong Month, Week Lower
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
ETFs positioned on MEREO BIOPHARMA GROUP PLCETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
Invesco Nasdaq Biotechnology ETF - USD0.01%-1.19%-United_States
IShares Nasdaq US Biotechnology (D) - USD0.01%-0.75%United_States
IShares Nasdaq US Biotechnology - USD0.01%-0.78%United_States
IShares Biotechnology ETF - USD0.01%-0.93%-NC



Copyright ę 2009 Morningstar. All Rights Reserved. The information, data and opinions expressed (ôInformationö) and contained herein: (1) are proprietary to Morningstar and/or its content providers and are not intended to represent investment advice or recommendation to buy or sell any security; (2) may not be copied or distributed without express license to do so; and (3) are not warranted to be accurate, complete or timely. Morningstar reserve its rights to charge for access to these Ratings and/or Rating report. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this Rating, Rating Report or Information contained therein.
Chart MEREO BIOPHARMA GROUP PLC
Duration : Period :
Mereo BioPharma Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 65,05 GBX
Average target price 370,20 GBX
Spread / Average Target 469%
Chart MEREO BIOPHARMA GROUP PLC
Duration : Period :
Mereo BioPharma Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Sector and Competitors
1st jan.Capi. (M$)
MEREO BIOPHARMA GROUP PLC-50.31%86
VERTEX PHARMACEUTICALS44.62%82 480
REGENERON PHARMACEUTICALS, INC.21.02%81 748
BIONTECH SE-33.36%41 753
WUXI APPTEC CO., LTD.-32.53%33 492
GENMAB A/S23.08%29 964